Repressed β-1,3-galactosyltransferase in the Tn syndrome

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1406, Issue 1, 1998, Pages 115-125

  Mrkoci Felner, Kristina ^a   Dinter, André ^a   Cartron, Jean Pierre ^b   Berger, Eric G ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b INSERM   (France)

Author keywords

5 azacytidine; Na n butyrate; Permanent mixed field polyagglutinability; Thomsen Friedenreich antigen

Indexed keywords

AZACITIDINE; BUTYRIC ACID; GALACTOSYLTRANSFERASE; T LYMPHOCYTE ANTIGEN;

AGED; ALLELE; ARTICLE; CASE REPORT; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE REPRESSION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BIOLOGICAL MARKERS; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMATOLOGIC DISEASES; HUMANS; SYNDROME;

EID: 0344447086     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(97)00090-2     Document Type: Article

References (16)

1. Sturgeon P., Luner S.J., McQuiston D.T. Permanent mixed-field polyagglutinability (PMFP): II. Hematological, biophysical and biochemical observations. Vox Sang. 25:1973;498-512.
2. Brouet J.C., Vainchenker W., Blanchard D., Testa U., Cartron J.P. The origin of human B and T cells from multipotent stem cells: a study of Tn syndrome. Eur. J. Immunol. 13:1983;350-352.
3. Berger E.G., Dinter A., Thurnher M. Mucin type galactosyltransferase: enzymology and deficiency in the Tn-syndrome. Trends Glycosci. Glycotechnol. 6:1994;51-63.
4. Berger E.G., Kozdrowski I. Permanent mixed-field polyagglutinable erythrocytes lack galactosyltransferase activity. FEBS Lett. 93:1978;105-108.
5. Cartron J.P., Andreu G., Cartron J., Bird G.W.G., Salmon C., Gerbal A. Demonstration of T-transferase deficiency in Tn-polyagglutinable blood samples. Eur. J. Biochem. 92:1978;111-119.
6. Thurnher M., Rusconi S., Berger E.G. Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. J. Clin. Invest. 91:1993;2103-2110.
7. Thurnher M., Clausen H., Fierz W., Lanzavecchia A., Berger E.G. T-cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability. Eur. J. Immunol. 22:1992;1835-1842.
8. Fattorusso, O. Ritter, Vademecum Clinique, Masson, Paris, 1994.
9. Berger E.G., Thurnher M. Clues to cell-specific synthesis of complex carbohydrates. News Physiol. Sci. 8:1993;57-60.
10. Stevens V.L. Biosynthesis of glycosylphosphatidylinositol membrane anchors. Biochem. J. 310:1995;361-370.
11. Shah S., Lance P., Smith T.J., Berenson C.S., Cohen S.A., Horvath P.J., Lau J.T., Baumann H. N-butyrate reduces the expression of β-galactoside α-2,6-sialyltransferase in HepG2 cells. J. Biol. Chem. 267:1992;10652-10658.
12. Datti A., Dennis J.W. Regulation of UDP-GlcNAc:Galβ1-3GalNAc-R β1-6-N-acetylglucosaminyltransferase (GlcNAc to GalNAc) in Chinese hamster ovary cells. J. Biol. Chem. 268:1993;5409-5416.
13. Piller F., Piller V., Fox R.I., Fukuda M. Human T-lymphocyte activation is associated with changes on O-glycan biosynthesis. J. Biol. Chem. 263:1988;15146-15150.
14. Potvin B., Stanley P. Activation of two new α-1,3-fucosyltransferase activities in Chinese hamster ovary cells by 5-azacytidine. Cell Regul. 2:1991;989-1000.
15. Kudo S., Fukuda M. Tissue-specific transcriptional regulation of human leukosialin (CD43) gene is achieved by DNA methylation. J. Biol. Chem. 270:1995;13298-13302.
16. Tomana M., Julian B.A., Waldo F.B., Kulhavy R., Mestecky J. IgA nephropathy. A disease of incomplete IgA1 glycosylation? Adv. Exp. Med. Biol. 376:1995;221.